3BNC117 and 10-1074 in HIV-infected Individuals

NCT02825797 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Human Immunodeficiency Virus (HIV)

Interventions

DRUG: 3BNC117
DRUG: 10-1074
OTHER: Analytical treatment interruption
DRUG: Placebo

Sponsor

Rockefeller University

Collaborators

[object Object]